MATINAS BIOPHARMA HOLDINGS, INC. Operating Lease Cost
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Operating Lease Cost of $3.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, cost for the quarter ending 2026-06-30 was $3.00K, a 98.25% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, cost for the quarter ending 2026-03-31 was $165.00K, a 5.17% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, cost for the quarter ending 2025-12-31 was $121.00K, a 48.51% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, cost for the quarter ending 2025-09-30 was $168.00K, a 25.33% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, cost for fiscal 2025 was $634.00K, a 29.71% decline from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, cost for fiscal 2024 was $902.00K, a 0.00% change from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, cost for fiscal 2023 was $902.00K, a 3.44% increase from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. operating lease, cost for fiscal 2022 was $872.00K, a 2.35% increase from fiscal 2021.
| Period end | Operating Lease, Cost 0 month | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-13 | $104.00K 10-Q · filed 2026-08-13 | $289.00K derived: sum of 3 quarters · filed 2026-08-13 | $457.00K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $165.00K 10-Q · filed 2026-05-08 | $286.00K derived: sum of 2 quarters · filed 2026-05-08 | $454.00K derived: sum of 3 quarters · filed 2026-05-08 | $625.00K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $289.00K derived: sum of 2 quarters · filed 2026-03-31 | $460.00K derived: sum of 3 quarters · filed 2026-08-13 | $634.00K 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $168.00K 10-Q · filed 2025-11-10 | $339.00K derived: sum of 2 quarters · filed 2026-08-13 | $513.00K 10-Q · filed 2025-11-10 | $748.00K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $171.00K 10-Q · filed 2026-08-13 | $345.00K 10-Q · filed 2026-08-13 | $580.00K derived: sum of 3 quarters · filed 2026-08-13 | $805.00K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $174.00K 10-Q · filed 2026-05-08 | $409.00K derived: sum of 2 quarters · filed 2026-05-08 | $634.00K derived: sum of 3 quarters · filed 2026-05-08 | $860.00K derived: sum of 4 quarters · filed 2026-05-08 | |||||
| 2024-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $460.00K derived: sum of 2 quarters · filed 2026-03-31 | $686.00K derived: sum of 3 quarters · filed 2026-03-31 | $902.00K 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $225.00K 10-Q · filed 2025-11-10 | $451.00K derived: sum of 2 quarters · filed 2025-11-10 | $667.00K 10-Q · filed 2025-11-10 | $677.00K 10-Q · filed 2024-11-13 | $902.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $226.00K 10-Q · filed 2025-08-14 | $452.00K 10-Q · filed 2025-08-14 | $677.00K derived: sum of 3 quarters · filed 2025-08-14 | $902.00K derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $226.00K 10-Q · filed 2025-05-15 | $451.00K derived: sum of 2 quarters · filed 2025-05-15 | $676.00K derived: sum of 3 quarters · filed 2025-05-15 | $902.00K derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $450.00K derived: sum of 2 quarters · filed 2025-04-15 | $676.00K derived: sum of 3 quarters · filed 2025-04-15 | $902.00K 10-K · filed 2025-04-15 | |||||
| 2023-09-30 | $225.00K 10-Q · filed 2024-11-13 | $451.00K derived: sum of 2 quarters · filed 2024-11-13 | $677.00K 10-Q · filed 2024-11-13 | $903.00K derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $226.00K 10-Q · filed 2024-08-14 | $452.00K 10-Q · filed 2024-08-14 | $678.00K derived: sum of 3 quarters · filed 2024-08-14 | $872.00K derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | $226.00K 10-Q · filed 2024-05-09 | $452.00K derived: sum of 2 quarters · filed 2024-05-09 | $646.00K derived: sum of 3 quarters · filed 2024-05-09 | $872.00K derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | $226.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $420.00K derived: sum of 2 quarters · filed 2024-03-27 | $646.00K derived: sum of 3 quarters · filed 2024-03-27 | $872.00K 10-K · filed 2024-03-27 | |||||
| 2022-09-30 | $194.00K 10-Q · filed 2023-11-08 | $420.00K derived: sum of 2 quarters · filed 2023-11-08 | $646.00K 10-Q · filed 2023-11-08 | $872.00K derived: sum of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | $226.00K 10-Q · filed 2023-08-09 | $452.00K 10-Q · filed 2023-08-09 | $678.00K derived: sum of 3 quarters · filed 2023-08-09 | $897.00K derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-03-31 | $226.00K 10-Q · filed 2022-05-12 | $452.00K derived: sum of 2 quarters · filed 2023-03-15 | $671.00K derived: sum of 3 quarters · filed 2023-03-15 | $875.00K derived: sum of 4 quarters · filed 2023-03-15 | |||||
| 2021-12-31 | $226.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $445.00K derived: sum of 2 quarters · filed 2023-03-15 | $649.00K derived: sum of 3 quarters · filed 2023-03-15 | $852.00K 10-K · filed 2023-03-15 | |||||
| 2021-09-30 | $219.00K 10-Q · filed 2022-11-02 | $423.00K derived: sum of 2 quarters · filed 2022-11-02 | $626.00K 10-Q · filed 2022-11-02 | $830.00K derived: sum of 4 quarters · filed 2022-11-02 | |||||
| 2021-06-30 | $204.00K 10-Q · filed 2022-08-11 | $407.00K 10-Q · filed 2022-08-11 | $611.00K derived: sum of 3 quarters · filed 2022-08-11 | $814.00K derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | $203.00K 10-Q · filed 2022-05-12 | $407.00K derived: sum of 2 quarters · filed 2022-05-12 | $610.00K derived: sum of 3 quarters · filed 2022-05-12 | $813.00K derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $204.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $407.00K derived: sum of 2 quarters · filed 2022-03-11 | $610.00K derived: sum of 3 quarters · filed 2022-03-11 | $814.00K 10-K/A · filed 2022-03-11 | $813.70K 10-K · filed 2021-03-29 | ||||
| 2020-09-30 | $203.00K 10-Q · filed 2021-11-08 | $203.40K 10-Q · filed 2020-11-06 | $406.00K derived: sum of 2 quarters · filed 2021-11-08 | $610.00K 10-Q · filed 2021-11-08 | $203.40K 10-Q · filed 2020-11-06 | $812.40K derived: sum of 4 quarters · filed 2021-11-08 | |||
| 2020-09-23 | $1.80M 10-Q · filed 2021-08-10 | ||||||||
| 2020-06-30 | $203.00K 10-Q · filed 2021-08-10 | $203.40K 10-Q · filed 2020-08-10 | $407.00K 10-Q · filed 2021-08-10 | $203.40K 10-Q · filed 2020-08-10 | $609.40K derived: sum of 3 quarters · filed 2021-08-10 | $1.22M derived: sum of 4 quarters · filed 2021-08-10 | |||
| 2020-03-31 | $203.00K 10-Q · filed 2021-05-10 | $203.40K 10-Q · filed 2020-05-11 | $406.40K derived: sum of 2 quarters · filed 2021-05-10 | $1.02M derived: sum of 3 quarters · filed 2021-05-10 | $1.42M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $203.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $813.70K derived: sum of 2 quarters · filed 2021-03-29 | $1.22M derived: sum of 3 quarters · filed 2021-03-29 | $813.70K 10-K · filed 2021-03-29 | $814.00K 10-K · filed 2020-03-09 | ||||
| 2019-09-30 | $610.30K 10-Q · filed 2020-11-06 | $203.00K 10-Q · filed 2019-11-13 | $1.02M derived: sum of 2 quarters · filed 2020-11-06 | $610.30K 10-Q · filed 2020-11-06 | $610.00K 10-Q · filed 2019-11-13 | $1.41M derived: sum of 4 quarters · filed 2020-11-06 | |||
| 2019-06-30 | $406.80K 10-Q · filed 2020-08-10 | $203.00K 10-Q · filed 2019-08-13 | $406.80K 10-Q · filed 2020-08-10 | $407.00K 10-Q · filed 2019-08-13 | $796.20K derived: sum of 3 quarters · filed 2020-08-10 | $982.20K derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $203.40K 10-Q · filed 2020-05-11 | $203.43K 10-Q · filed 2019-05-13 | $389.40K derived: sum of 2 quarters · filed 2020-05-11 | $575.40K derived: sum of 3 quarters · filed 2020-05-11 | $761.40K derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $372.00K derived: sum of 2 quarters · filed 2020-03-09 | $558.00K derived: sum of 3 quarters · filed 2020-03-09 | $745.00K 10-K · filed 2020-03-09 | |||||
| 2018-09-30 | $186.00K 10-Q · filed 2019-11-13 | $372.00K derived: sum of 2 quarters · filed 2019-11-13 | $559.00K 10-Q · filed 2019-11-13 | ||||||
| 2018-06-30 | $186.00K 10-Q · filed 2019-08-13 | $373.00K 10-Q · filed 2019-08-13 | |||||||
| 2018-03-31 | $186.32K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |